Andrew John Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrew John Li has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Beth Y. Karlan
Division of Gynecologic Oncology, Women's Cancer Program, Cedars-Sinai Medical Center, 8635 West 3rd Street, Suite 280W, Los Angeles, CA 90048, USA
9 shared publications- Beth Y. Karlan
Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
4 shared publications - Bobbie J. Rimel
University of Washington, Seattle, WA
4 shared publications - Arthur-Quan Tran
Department of Obstetrics and Gynecology, Cedars–Sinai Medical Center, Los Angeles, CA
2 shared publications - Christine S. Walsh
Cedars-Sinai Medical Center
2 shared publications Ilana Cass
Division of Gynecologic Oncology, Women's Cancer Program, Cedars-Sinai Medical Center, 8635 West 3rd Street, Suite 280W, Los Angeles, CA 90048, USA
2 shared publications
Latest Publications
- Open Access
DNA methylation landscapes of matched primary and recurrent high grade serous ovarian cancers are preserved throughout disease progression and chemoresistance
Little is known about the role of global DNA methylation in recurrence and chemoresistance of high grade serous ovarian cancer (HGSOC). We performed whole genome bisulfite sequencing (WGBS) and whole transcriptome sequencing (RNA-seq) to establish methylation and gene expression signatures in 62 primary and recurrent tumors from 28 patients diagnosed with stage III/IV HGSOC. Eleven of these patients carried pathogenic germline BRCA1/BRCA2 mutations. Genome-wide methylation and transcriptomic features identified in primary tumors were largely preserved in matched recurrent tumors from the same patient (P-value = 7.16 × 10 −7 and 1.41 × 10 −3 in BRCA1/2 and non- BRCA1/2 cases respectively). Tumors from BRCA1/2 carriers displayed high levels of heterogeneity, with significantly more shared methylation changes identified between primary and recurrent tumors from non- BRCA1/2 patients, which may be related to the poorer survival we observe in HGSOCs from non- BRCA1/2 carriers (P-value = 0.0056). Partially methylated domains (PMDs) dominated the epigenetic variation across all tumors, and were more hypomethylated in BRCA1/2 than non- BRCA1/2 cases. Differential gene expression analysis identified upregulation of genes from immune pathways including antigen processing and presentation in tumors from BRCA1/2 carriers, implicating increased immune response in the improved survival observed in these patients. In summary, this study shows a previously unreported conservation of methylation and gene expression in recurrent HGSOCs. These data have implications for the possible effectiveness of epigenetic based therapies to treat both primary and recurrent ovarian cancers.
Open AccessDNA methylation landscapes of matched primary and recurrent high grade serous ovarian cancers are preserved throughout disease progression and chemoresistance
Little is known about the role of global DNA methylation in recurrence and chemoresistance of high grade serous ovarian cancer (HGSOC). We performed whole genome bisulfite sequencing (WGBS) and whole transcriptome sequencing (RNA-seq) to establish methylation and gene expression signatures in 62 primary and recurrent tumors from 28 patients diagnosed with stage III/IV HGSOC. Eleven of these patients carried pathogenic germline BRCA1/BRCA2 mutations. Genome-wide methylation and transcriptomic features identified in primary tumors were largely preserved in matched recurrent tumors from the same patient (P-value = 7.16 × 10 −7 and 1.41 × 10 −3 in BRCA1/2 and non- BRCA1/2 cases respectively). Tumors from BRCA1/2 carriers displayed high levels of heterogeneity, with significantly more shared methylation changes identified between primary and recurrent tumors from non- BRCA1/2 patients, which may be related to the poorer survival we observe in HGSOCs from non- BRCA1/2 carriers (P-value = 0.0056). Partially methylated domains (PMDs) dominated the epigenetic variation across all tumors, and were more hypomethylated in BRCA1/2 than non- BRCA1/2 cases. Differential gene expression analysis identified upregulation of genes from immune pathways including antigen processing and presentation in tumors from BRCA1/2 carriers, implicating increased immune response in the improved survival observed in these patients. In summary, this study shows a previously unreported conservation of methylation and gene expression in recurrent HGSOCs. These data have implications for the possible effectiveness of epigenetic based therapies to treat both primary and recurrent ovarian cancers.
- 1 August 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 138 (2) , 263-266
Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancer
- 1 August 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 138 (2) , 263-266
Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancer
- 1 March 2014
- Published by Elsevier in Gynecologic Oncology
- Vol. 132 (3) , 556-559
Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival
- 1 March 2014
- Published by Elsevier in Gynecologic Oncology
- Vol. 132 (3) , 556-559
Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival
- 1 October 2013
- Published by Elsevier in Gynecologic Oncology
- Vol. 131 (1) , 261-262
Obesity correlates with overall survival in women with recurrent epithelial ovarian cancer
- 1 October 2013
- Published by Elsevier in Gynecologic Oncology
- Vol. 131 (1) , 261-262
Obesity correlates with overall survival in women with recurrent epithelial ovarian cancer
- 28 August 2010
- Vol. 55, 346-50
Effect of cigarette smoking on epithelial ovarian cancer survival.
To determine associations between smoking and survival in patients with ovarian cancer. We performed a retrospective review of patients undergoing surgery for ovarian cancer. Abstracted patient data included age, smoking history, stage, grade, extent of cytoreduction, and survival. Data were examined with Fisher's exact test, Kaplan-Meier survival analysis, and Cox regression analysis. A total of 130 patients met criteria for review. Seventeen (13%) smoked cigarettes at the time of initial laparotomy. Twenty-one (16%) were left with > 1 cm residual disease. Smoking did not correlate with the incidence of suboptimal cytoreduction. There were no statistical differences in incidence of hypertension, obesity, or coronary artery disease in smokers compared to nonsmokers. Smoking was found to negatively influence length of progression-free survival. Similarly, smokers were found to have decreased disease-specific overall survival compared to nonsmokers. Cigarette smoking retained independent significance as poor prognostic factors, after controlling for age, stage, and grade. These findings identify a negative correlation with cigarette smoking and survival in women with ovarian cancer. Further studies are proposed to elucidate the molecular mechanisms underlying these clinical observations.
- 28 August 2010
- Vol. 55, 346-50
Effect of cigarette smoking on epithelial ovarian cancer survival.
To determine associations between smoking and survival in patients with ovarian cancer. We performed a retrospective review of patients undergoing surgery for ovarian cancer. Abstracted patient data included age, smoking history, stage, grade, extent of cytoreduction, and survival. Data were examined with Fisher's exact test, Kaplan-Meier survival analysis, and Cox regression analysis. A total of 130 patients met criteria for review. Seventeen (13%) smoked cigarettes at the time of initial laparotomy. Twenty-one (16%) were left with > 1 cm residual disease. Smoking did not correlate with the incidence of suboptimal cytoreduction. There were no statistical differences in incidence of hypertension, obesity, or coronary artery disease in smokers compared to nonsmokers. Smoking was found to negatively influence length of progression-free survival. Similarly, smokers were found to have decreased disease-specific overall survival compared to nonsmokers. Cigarette smoking retained independent significance as poor prognostic factors, after controlling for age, stage, and grade. These findings identify a negative correlation with cigarette smoking and survival in women with ovarian cancer. Further studies are proposed to elucidate the molecular mechanisms underlying these clinical observations.
- 1 January 2010
- Published by Elsevier in Gynecologic Oncology
- Vol. 116 (1) , 78-81
Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers
- 1 January 2010
- Published by Elsevier in Gynecologic Oncology
- Vol. 116 (1) , 78-81
Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers
- 1 January 2010
- Published by Elsevier in Gynecologic Oncology
- Vol. 116 (1) , 105-108
Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers
- 1 January 2010
- Published by Elsevier in Gynecologic Oncology
- Vol. 116 (1) , 105-108
Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers
- 31 January 2009
- Published by Elsevier in Gynecologic Oncology
- Vol. 112 (1) , 287
Book Review
- 1 November 2008
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 7 (11) , 1712-1716
Androgens and epithelial ovarian cancer: What's the connection?
Epithelial ovarian cancer remains the most lethal of all the gynecologic malignancies, and is characterized by significant clinical heterogeneity. Variables include the number and site of metastase...
- 1 November 2008
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 7 (11) , 1712-1716
Androgens and epithelial ovarian cancer: What's the connection?
Epithelial ovarian cancer remains the most lethal of all the gynecologic malignancies, and is characterized by significant clinical heterogeneity. Variables include the number and site of metastase...